Jw Pharmac Working Capital to Net Assets Ratio
Jw Pharmac working capital to net assets ratio. Jw Pharmac (001060) has a Working Capital to Net Assets ratio of 25.5% as of March 2026. Working capital of ₩97.54 Billion (current assets of ₩308.90 Billion minus current liabilities of ₩211.35 Billion) is measured against net assets of ₩381.78 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Jw Pharmac (001060) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Jw Pharmac (2013–2025)
Working capital to net assets ratio of Jw Pharmac from 2013 to 2025. This chart shows how Jw Pharmac's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 25.5%, reflecting working capital of ₩97.54 Billion against net assets of ₩381.78 Billion KRW. See Jw Pharmac liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Jw Pharmac Working Capital to Net Assets Ratio by Year (2013–2025)
Jw Pharmac working capital to net assets ratio by year from 2013 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Jw Pharmac from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Jw Pharmac balance sheet assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 23.6% | ₩87.35 Billion | ₩369.37 Billion | ₩296.51 Billion | ₩209.16 Billion | ▼ -6.0 pp |
| 2024 | 29.7% | ₩97.80 Billion | ₩329.49 Billion | ₩306.41 Billion | ₩208.62 Billion | ▼ -4.7 pp |
| 2023 | 34.3% | ₩91.16 Billion | ₩265.44 Billion | ₩378.09 Billion | ₩286.93 Billion | ▲ +14.3 pp |
| 2022 | 20.1% | ₩45.33 Billion | ₩225.76 Billion | ₩425.46 Billion | ₩380.13 Billion | ▼ -24.4 pp |
| 2021 | 44.4% | ₩83.77 Billion | ₩188.54 Billion | ₩366.45 Billion | ₩282.68 Billion | ▲ +13.3 pp |
| 2020 | 31.1% | ₩64.58 Billion | ₩207.47 Billion | ₩299.33 Billion | ₩234.75 Billion | ▲ +6.3 pp |
| 2019 | 24.8% | ₩57.07 Billion | ₩230.09 Billion | ₩335.06 Billion | ₩277.98 Billion | ▼ -31.1 pp |
| 2018 | 56.0% | ₩145.54 Billion | ₩260.11 Billion | ₩373.91 Billion | ₩228.37 Billion | ▲ +5.4 pp |
| 2017 | 50.5% | ₩136.83 Billion | ₩270.78 Billion | ₩411.37 Billion | ₩274.54 Billion | ▼ -9.1 pp |
| 2016 | 59.6% | ₩164.67 Billion | ₩276.31 Billion | ₩422.64 Billion | ₩257.98 Billion | ▲ +8.4 pp |
| 2015 | 51.2% | ₩115.39 Billion | ₩225.41 Billion | ₩376.17 Billion | ₩260.78 Billion | ▼ -7.8 pp |
| 2014 | 59.0% | ₩132.06 Billion | ₩223.83 Billion | ₩343.50 Billion | ₩211.44 Billion | ▲ +55.1 pp |
| 2013 | 3.9% | ₩7.82 Billion | ₩200.74 Billion | ₩324.09 Billion | ₩316.28 Billion | — |